News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
696,980 Results
Type
Article (39594)
Company Profile (247)
Press Release (657139)
Multimedia
Podcasts (46)
Webinars (12)
Section
Business (204114)
Career Advice (2007)
Deals (35412)
Drug Delivery (95)
Drug Development (81022)
Employer Resources (172)
FDA (16165)
Job Trends (14848)
News (345087)
Policy (32513)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2553)
Accelerated approval (5)
Adcomms (20)
Allergies (82)
Alliances (49389)
ALS (85)
Alzheimer's disease (1365)
Antibody-drug conjugate (ADC) (111)
Approvals (16165)
Artificial intelligence (237)
Autoimmune disease (19)
Automation (15)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (18)
Biosimilars (102)
Biotechnology (175)
Bladder cancer (60)
Brain cancer (26)
Breast cancer (258)
Cancer (2063)
Cardiovascular disease (164)
Career advice (1674)
Career pathing (29)
CAR-T (143)
Cell therapy (400)
Cervical cancer (19)
Clinical research (65807)
Collaboration (781)
Compensation (498)
Complete response letters (19)
COVID-19 (2581)
CRISPR (37)
C-suite (221)
Cystic fibrosis (100)
Data (2035)
Decentralized trials (2)
Denatured (17)
Depression (39)
Diabetes (255)
Diagnostics (6347)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (117)
Drug pricing (95)
Drug shortages (25)
Duchenne muscular dystrophy (88)
Earnings (86287)
Editorial (33)
Employer branding (21)
Employer resources (146)
Events (111822)
Executive appointments (674)
FDA (17319)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (706)
Gene editing (99)
Generative AI (19)
Gene therapy (282)
GLP-1 (692)
Government (4397)
Grass and pollen (4)
Guidances (50)
Healthcare (18811)
Huntington's disease (22)
IgA nephropathy (24)
Immunology and inflammation (105)
Indications (26)
Infectious disease (2719)
Inflammatory bowel disease (132)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (90)
Interviews (311)
IPO (16493)
IRA (40)
Job creations (3628)
Job search strategy (1422)
Kidney cancer (9)
Labor market (35)
Layoffs (458)
Leadership (16)
Legal (7905)
Liver cancer (72)
Lung cancer (299)
Lymphoma (139)
Machine learning (5)
Management (58)
Manufacturing (275)
MASH (62)
Medical device (13337)
Medtech (13342)
Mergers & acquisitions (19423)
Metabolic disorders (650)
Multiple sclerosis (73)
NASH (16)
Neurodegenerative disease (82)
Neuropsychiatric disorders (24)
Neuroscience (1864)
NextGen: Class of 2025 (6512)
Non-profit (4476)
Northern California (2507)
Now hiring (37)
Obesity (349)
Opinion (203)
Ovarian cancer (73)
Pain (80)
Pancreatic cancer (79)
Parkinson's disease (144)
Partnered (21)
Patents (217)
Patient recruitment (99)
Peanut (46)
People (57168)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20496)
Phase II (28974)
Phase III (21600)
Pipeline (1100)
Policy (123)
Postmarket research (2563)
Preclinical (8667)
Press Release (64)
Prostate cancer (97)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (368)
Real estate (5906)
Recruiting (65)
Regulatory (22185)
Reports (46)
Research institute (2319)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (40)
Schizophrenia (65)
Series A (123)
Series B (80)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2164)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3572)
State (2)
Stomach cancer (13)
Supply chain (62)
Tariffs (16)
The Weekly (27)
United States (21757)
Vaccines (661)
Venture capitalists (37)
Weight loss (227)
Women's health (34)
Worklife (15)
Date
Today (111)
Last 7 days (460)
Last 30 days (2413)
Last 365 days (33109)
2025 (8877)
2024 (35219)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (718)
Alabama (51)
Alaska (7)
Arizona (228)
Arkansas (13)
Asia (37738)
Australia (6174)
California (5703)
Canada (1922)
China (485)
Colorado (249)
Connecticut (262)
Delaware (132)
Europe (80969)
Florida (851)
Georgia (199)
Idaho (57)
Illinois (505)
India (24)
Indiana (296)
Iowa (9)
Japan (147)
Kansas (102)
Kentucky (23)
Louisiana (9)
Maine (62)
Maryland (846)
Massachusetts (4285)
Michigan (214)
Minnesota (377)
Mississippi (2)
Missouri (78)
Montana (27)
Nebraska (25)
Nevada (58)
New Hampshire (62)
New Jersey (1632)
New Mexico (28)
New York (1632)
North Carolina (931)
North Dakota (7)
Northern California (2507)
Ohio (194)
Oklahoma (14)
Oregon (33)
Pennsylvania (1288)
Puerto Rico (11)
Rhode Island (29)
South America (1095)
South Carolina (19)
South Dakota (1)
Southern California (2164)
Tennessee (96)
Texas (848)
Utah (170)
Virginia (135)
Washington D.C. (59)
Washington State (525)
West Virginia (3)
Wisconsin (51)
696,980 Results for "xilis inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Xilis and MD Anderson Announce Strategic Collaboration to Advance Novel Technology and Accelerate Therapeutic Development
Xilis and The University of Texas MD Anderson Cancer Center today announced a strategic collaboration to deploy Xilis’s proprietary MicroOrganoSphere™ (MOS) technology in support of preclinical research to accelerate the development of novel cancer therapies.
February 15, 2023
·
5 min read
Business
Xilis Announces Formation of its Scientific Advisory Board
Xilis today announced the addition of four members to its newly formed Scientific Advisory Board (SAB).
December 15, 2022
·
5 min read
Bio NC
Xilis Participates in €325MM Oncode-PACT Consortium to Accelerate the Development of Cancer Drugs
Xilis, Inc. announced that it is participating in the recently announced public-private Oncode-PACT.
May 3, 2022
·
4 min read
Bio NC
Xilis Announces Series A Extension, Bringing Total Round to Over US$89 Million
Xilis, Inc., a pioneering biotechnology company developing its MicroOrganoSphere™ (MOS™) technology to guide precision therapy for cancer patients and accelerate drug discovery and development, has closed an extension of over US$19 million to its Series A financing round, bringing the total amount raised to over US$89 million.
July 13, 2022
·
4 min read
Business
Xilis Announces Breast Cancer Oncologist Dr. Daniel F. Hayes to Join Clinical Advisory Board
Xilis expands CAB to five members to help company develop its MicroOrganoSphere™ technology.
June 8, 2022
·
4 min read
Press Releases
Nika Pharmaceuticals, Inc. (NIKA) Latest Developments
April 14, 2025
·
2 min read
Press Releases
Accord BioPharma, Inc. Announces Completion of UDENYCA® (pegfilgrastim-cbqv) Franchise Acquisition from Coherus BioSciences, Inc., Expanding U.S. Biosimilar Portfolio
April 14, 2025
·
9 min read
Press Releases
Dogwood Therapeutics, Inc. Regains Nasdaq Compliance
April 3, 2025
·
4 min read
Press Releases
FOXO TECHNOLOGIES INC. ANNOUNCES EXECUTION OF A NON BINDING AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.
March 20, 2025
·
4 min read
Press Releases
Kane Biotech Announces New Agreement with Outside the Box Capital Inc.
April 14, 2025
·
3 min read
1 of 69,698
Next
